<h4>Background</h4>Aberrant metabotropic glutamate receptor 2/3 (mGluR2/3) signaling has been implicated in the synaptic and cognitive deficits observed in Alzheimer's disease (AD), yet the underlying regulatory mechanisms remain unclear. This evidence concerns the gene GRM2 and early-onset autosomal dominant Alzheimer disease.